News
Multidrug-resistant tuberculosis (MDR-TB) is an infection in which Mycobacterium tuberculosis (TB) is resistant to at least rifampin and isoniazid. (1) Second-line antituberculosis drugs are ...
Genomic analysis studies reveal that isoniazid resistance overwhelmingly develops earlier than resistance to other antituberculosis drugs. When rifampicin resistance is detected, pre-existing ...
Hyb_SEnc: An Antituberculosis Peptide Predictor Based on a Hybrid Feature Vector and Stacked Ensemble Learning Tuberculosis has plagued mankind since ancient times, and the struggle between humans and ...
ABSTRACT: Introduction: Resistance to antituberculosis drugs and adverse drug reactions remain the leading causes of tuberculosis therapeutic failure globally. Despite the increasing acceptance of ...
New Delhi: In a significant move to ensure adequate availability, invoking para 3 of the Drugs (Prices Control) Order, 2013, the National Pharmaceutical Pricing Authority (NPPA) has directed Macleods ...
No patients with EPTB were included in the study. After completion of antituberculosis treatment in the present study, there was a significant increase in cortisol levels both at baseline and 60 ...
Antituberculosis therapy was started, resulting in hematological remission. “This treatment response indicated that disseminated tuberculosis was responsible for the aplastic crisis, leukemic cell ...
The current standard treatment for tuberculosis (TB) consists of a combination of four antibiotics administered for 6 to 12 months. There is hence a clear need for new strategies both for shorter ...
Optimal antituberculosis therapy is essential for favourable clinical outcomes particularly in severely ill children. Using WHO-recommended weight-band dosing, younger children weighing <8kg are at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results